Institutional Ownership Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT). We have compiled data on the 250 institutions that hold shares in the stock, with a total of 126 Million shares, which have been reported (via 13F filing form) to have a value of $1.72 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Suvretta Capital Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
11,422,978
shares
|
$156 Million
7.82% of portfolio
|
Q1 2025
Added 0.21%
|
|
|
Jennison Associates LLC
|
May 02, 2025 Q1 2025 |
11,360,875
shares
|
$155 Million
0.13% of portfolio
|
Q1 2025
Reduced 7.93%
|
|
|
Rubric Capital Management LP
New York, NY |
May 14, 2025 Q1 2025 |
10,966,672
shares
|
$149 Million
4.91% of portfolio
|
Q3 2024
Added 11.71%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
8,785,284
shares
|
$120 Million
8.65% of portfolio
|
Q1 2024
Added 0.24%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,622,618
shares
|
$118 Million
0.0% of portfolio
|
Q2 2024
Added 29.49%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
6,818,078
shares
|
$92.9 Million
0.0% of portfolio
|
Q1 2025
Added 5.86%
|
|
|
Polar Capital Holdings PLC
London, X0 |
May 15, 2025 Q1 2025 |
6,706,475
shares
|
$91.4 Million
0.7% of portfolio
|
Q1 2025
Reduced 9.09%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
4,474,203
shares
|
$61 Million
0.0% of portfolio
|
Q1 2025
Reduced 9.63%
|
|
|
Gilder Gagnon Howe & CO LLC
New York, NY |
May 15, 2025 Q1 2025 |
4,096,051
shares
|
$55.8 Million
0.91% of portfolio
|
Q1 2025
Added 4.95%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
3,838,541
shares
|
$52.3 Million
0.0% of portfolio
|
Q1 2025
Reduced 9.55%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
2,920,008
shares
|
$39.8 Million
0.01% of portfolio
|
Q1 2025
Added 4.68%
|
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2025 Q1 2025 |
2,761,767
shares
|
$37.6 Million
0.01% of portfolio
|
Q1 2025
Reduced 16.55%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
2,546,947
shares
|
$34.7 Million
0.0% of portfolio
|
Q1 2025
Added 3.0%
|
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
May 14, 2025 Q1 2025 |
2,120,508
shares
|
$28.9 Million
46.38% of portfolio
|
Q3 2024
Added 3.89%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2025 Q1 2025 |
1,989,508
shares
|
$27.1 Million
0.03% of portfolio
|
Q1 2025
Reduced 20.85%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
1,988,389
shares
|
$27.1 Million
0.06% of portfolio
|
Q1 2025
Reduced 16.25%
|
|
|
American Century Companies Inc
Kansas City, MO |
May 13, 2025 Q1 2025 |
1,652,492
shares
|
$22.5 Million
0.02% of portfolio
|
Q1 2025
Added 1.3%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
May 05, 2025 Q1 2025 |
1,512,211
shares
|
$20.6 Million
0.22% of portfolio
|
Q1 2025
Reduced 2.06%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
1,465,334
shares
|
$20 Million
1.17% of portfolio
|
Q1 2025
New holding
|
|
|
Cormorant Asset Management, LP
Boston, MA |
May 15, 2025 Q1 2025 |
1,350,000
shares
|
$18.4 Million
2.24% of portfolio
|
Q1 2025
Reduced 26.03%
|
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
1,328,954
shares
|
$18.1 Million
0.0% of portfolio
|
Q1 2025
Added 17.95%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,327,029
shares
|
$18.1 Million
0.02% of portfolio
|
Q2 2023
Reduced 19.87%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
1,103,413
shares
|
$15 Million
0.0% of portfolio
|
Q1 2025
Reduced 15.52%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
1,092,735
shares
|
$14.9 Million
0.19% of portfolio
|
Q1 2025
Reduced 0.37%
|
|
|
Candriam S.C.A.
|
May 14, 2025 Q1 2025 |
1,035,576
shares
|
$14.1 Million
0.1% of portfolio
|
Q1 2025
Reduced 0.63%
|